Maccura Biotech secures four new product registrations

Maccura Biotechnology received product registration certificates for four in-vitro diagnostic reagents from national and provincial medical regulators. The new products detect Chlamydia pneumoniae IgM antibodies, Lipoprotein(a), Insulin-like Growth Factor-1, and Insulin-like Growth Factor Binding Protein-3.

The company now holds 136 product registration certificates for its direct chemiluminescence platform.